These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 30352428)

  • 1. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
    Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
    J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill
    Singh VK; Khan A; Xu Y; Mai S; Zhang L; Mishra A; Restrepo BI; Pan PY; Chen SH; Jagannath C
    Front Immunol; 2022; 13():865503. PubMed ID: 35757769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
    Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
    Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LILRB receptor-mediated regulation of myeloid cell maturation and function.
    van der Touw W; Chen HM; Pan PY; Chen SH
    Cancer Immunol Immunother; 2017 Aug; 66(8):1079-1087. PubMed ID: 28638976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of non-small cell lung cancer metastasis by knocking down APE1 through regulating myeloid-derived suppressor cells-induced immune disorders.
    Zhang Z; Lin Y; Pan X; Chen S
    Aging (Albany NY); 2024 Jun; 16(12):10435-10445. PubMed ID: 38885059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.
    Chen HM; Sun L; Pan PY; Wang LH; Chen SH
    Cancer Immunol Immunother; 2021 Dec; 70(12):3435-3449. PubMed ID: 33877384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.
    Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R
    Clin Cancer Res; 2017 Sep; 23(17):5187-5201. PubMed ID: 28698201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
    Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
    Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
    Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
    Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRPS2-mediated modulation of the antitumor immune response in lung cancer through CCL2-mediated tumor-associated macrophages and myeloid-derived suppressor cells.
    Liu Q; Wu N; Hou P
    Thorac Cancer; 2024 Aug; 15(23):1739-1748. PubMed ID: 38952044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
    Yang L; Wang B; Qin J; Zhou H; Majumdar APN; Peng F
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):91-97. PubMed ID: 29303012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors.
    Umiker B; Hashambhoy-Ramsay Y; Smith J; Rahman T; Mueller A; Davidson R; Meyer C; Patankar G; Alam MM; Jaffe S; Krukenberg K; Goodman A; Spaulding V; Priess M; Dhaneshwar A; Wong M; Diiorio A; O'Malley K; McGrath L; Willer M; Pepper L; Gostissa M; Kis-Toth K; Wiederschain D; Cohen H; Shaffer DR
    Mol Cancer Ther; 2023 Apr; 22(4):471-484. PubMed ID: 36780212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
    Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
    Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
    Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
    Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.
    Wiśniewski A; Kowal A; Wyrodek E; Nowak I; Majorczyk E; Wagner M; Pawlak-Adamska E; Jankowska R; Ślesak B; Frydecka I; Kuśnierczyk P
    Tissue Antigens; 2015 Jun; 85(6):466-75. PubMed ID: 25855135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.
    van der Touw W; Kang K; Luan Y; Ma G; Mai S; Qin L; Bian G; Zhang R; Mungamuri SK; Hu HM; Zhang CC; Aaronson SA; Feldmann M; Yang WC; Chen SH; Pan PY
    J Immunol; 2018 Sep; 201(6):1727-1734. PubMed ID: 30068593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells.
    Liang H; Shen X
    Biochem Biophys Res Commun; 2020 Jul; 528(2):330-335. PubMed ID: 32448508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
    Mami-Chouaib F; Echchakir H; Dorothée G; Vergnon I; Chouaib S
    Immunol Rev; 2002 Oct; 188():114-21. PubMed ID: 12445285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.